Immunotherapy before lung surgery shows promise in early trial

NCT ID NCT05577702

Completed Disease control Sponsor: BeiGene Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested giving the immunotherapy drug tislelizumab, alone or with other drugs, before surgery for people with stage II to IIIA non-small cell lung cancer that could be removed. The goal was to see if this approach could shrink tumors and improve outcomes. 121 adults took part, and the study looked at how much tumor remained after treatment and surgery.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

non-small cell lung carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

NON-SMALL CELL LUNG CANCER

Contacts and locations

Locations

Anyang Cancer Hospital

Anyang, Henan, 455001, China
Beijing Cancer Hospital

Beijing, Beijing Municipality, 100142, China
Fujian Medical University Union Hospital

Fuzhou, Fujian, 350001, China
Hubei Cancer Hospital

Wuhan, Hubei, 430079, China
Hunan Cancer Hospital

Changsha, Hunan, 410013, China
Hwa Mei Hospital, University of Chinese Academy of Sciences (Ningbo No Hospital)

Ningbo, Zhejiang, 315000, China
Liaoning Cancer Hospital and Institute

Shenyang, Liaoning, 110042, China
Rui Jin Hospital Shanghai Jiao Tong University School of Medicine

Shanghai, Shanghai Municipality, 200025, China
Shandong Cancer Hospital

Jinan, Shandong, 250117, China
Shanghai Pulmonary Hospital

Shanghai, Shanghai Municipality, 200433, China
The First Affiliated Hospital of Guangzhou Medical Universitydatansha Hospital)

Guangzhou, Guangdong, 510140, China
The First Affiliated Hospital of Nanchang University Branch Xianghu

Nanchang, Jiangxi, 332000, China
The First Affiliated Hospital of Wannan Medical College

Wuhu, Anhui, 241001, China
The Tumor Hospital Affiliated to Guangxi Medical University

Nanning, Guangxi, 530021, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.